Dr. Ellen G. Feigal, Deputy Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute
Dr. Valerie Beral, Professor, Imperial Cancer Research Fund, Cancer Epidemiology Unit, University of Oxford
Dr. Jay Berzofsky, Chief, Immunogenetics and Vaccine Research Section, Metabolism Branch, National Cancer Institute
Dr. Robert Biggar, International AIDS Coordinator, Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute
Dr. William Blattner, Institute of Human Virology, University of Maryland at Baltimore
Dr. Winston Cavert, Research Associate, Department of Microbiology, University of Minnesota
Dr. Kenneth J. Cremer, Program Director, AIDS Virus Study, Biological Carcinogenesis Branch, National Cancer Institute
Dr. Alvin Friedman-Kien, Professor of Dermatology and Microbiology, New York University Medical Center
Dr. Harold Jaffe, Associate Director for HIV/AIDS, National Center for Infectious Diseases Centers for Disease Control and Prevention
Dr. Elliott Kieff, Professor of Microbiology and Molecular Genetics, Infectious Disease Division, Channing Laboratory, Brigham and Woman's Hospital; Professor of Medicine, Harvard University
Dr. Michael M. Lederman, Professor of Medicine, Case Western University, University Hospitals of Cleveland
Dr. Douglas Lowy, Deputy Director, Division of Basic Sciences, National Cancer Institute
Dr. H. Kim Lyerly, Professor of Surgery, Assistant Professor, Pathology and Immunology, Duke University Medical Center
Mr. Michael Marco, Treatment Action Group
Dr. Brigitta U. Mueller, Associate Professor of Pediatrics, Harvard Medical School, Children=s Hospital
Dr. Thomas R. O'Brien, Senior Investigator, Epidemiology and Biostatistics Program, Division of Cancer Epidemiology, National Cancer Institute
Ms. Jaime Quinn, Program Specialist, Division of Cancer Treatment and Diagnosis, National Cancer Institute
Dr. Alan Rabson, Deputy Director, National Cancer Institute
Dr. David T. Scadden, Associate Professor of Medicine, Harvard Medical School, Massachusetts General Hospital
Dr. Jeffrey Schouten, Patient Advocate
Dr. Katherine Staskus, Senior Research Associate, Department of Microbiology, University of Minnesota
Dr. Roy S. Wu, Health Science Administrator, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute
Dr. Robert Yarchoan, Chief, HIV and AIDS Malignancy Branch, National Cancer Institute